1. Clinical & Scientific Overview
Loperamide Hydrochloride & Racecadotril (TIP-MED-000086, Reference Code [5.18]) is classified under
Gastrointestinal & Hepatobiliary Medicines (Ch 05) as a Peripheral Mu-Opioid Antidiarrhoeal & Antisecretory Enkephalinase Inhibitor (Schedule H).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Representative Indian Market Examples (Edition 2.7 Ch 05 [5.18], p. 68): Loperamide: Imodium (J&J), Eldoper (Micro Labs), Lopamide (Torrent). Racecadotril: Redotil (Dr. Reddy's), Zedott (Torrent), Enuff (Hetero) — Strengths & Dosage Forms: Loperamide Tablets/Capsules: 2 mg. Racecadotril: 100 mg Capsules (Adults); 10 mg & 30 mg Paediatric Granules/Sachets
Loperamide Tablets/Capsules: 2 mg. Racecadotril: 100 mg Capsules (Adults); 10 mg & 30 mg Paediatric Granules/Sachets
3. Mechanism of Action & Pharmacodynamics
Peripheral Mu-Opioid Antidiarrhoeal & Antisecretory Enkephalinase Inhibitor (Schedule H) acting on target receptor/enzyme pathways in Gastrointestinal & Hepatobiliary Medicines (Ch 05): clinical efficacy is mediated via Peripheral Mu-Opioid Antidiarrhoeal & Antisecretory Enkephalinase Inhibitor (Schedule H) for Loperamide: Symptomatic control of acute non-infectious watery diarrhoea, traveller's diarrhoea, and high-output ileostomy. Racecadotril: Physiological antisecretory therapy for acute secretory watery diarrhoea in adults and children (>3 months) alongside WHO ORS + Zinc.
4. Therapeutic Indications & Evidence-Supported Uses
- Loperamide: Symptomatic control of acute non-infectious watery diarrhoea, traveller's diarrhoea, and high-output ileostomy
- Racecadotril: Physiological antisecretory therapy for acute secretory watery diarrhoea in adults and children (>3 months) alongside WHO ORS + Zinc
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Loperamide (Adults): 4 mg (2 tabs) stat, then 2 mg after each loose stool (Max 16 mg/day for <=48 hours). Racecadotril (Adults): 100 mg PO TDS before meals (Max 7 days); Children (>3m): 1.5 mg/kg PO TDS
Administration & Meal Timing: Always administer alongside oral rehydration solution (WHO Low-Osmolarity ORS)! | Loperamide: After each loose stool. Racecadotril: Three times daily before main meals
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: No adjustment needed. Hepatic: Use caution in severe hepatic impairment (reduced first-pass clearance of Loperamide -> CNS sedation)
Renal: No adjustment needed. Hepatic: Use caution in severe hepatic impairment (reduced first-pass clearance of Loperamide -> CNS sedation)
Renal: No adjustment needed. Hepatic: Use caution in severe hepatic impairment (reduced first-pass clearance of Loperamide -> CNS sedation)
7. Contraindications, Precautions & High-Risk Warnings
- CONTRAINDICATIONS: Strictly contraindicated in acute dysentery (bloody/mucoid stools with high fever), suspected Shigella, Salmonella, or C. difficile colitis! Loperamide is CONTRAINDICATED in children <6–12 years (causes paralytic ileus & CNS depression!)
Key Clinical Precautions: Renal: No adjustment needed. Hepatic: Use caution in severe hepatic impairment (reduced first-pass clearance of Loperamide -> CNS sedation)
8. Adverse Effects Profile
- Loperamide: Constipation, abdominal cramps, nausea, dizziness. Racecadotril: Headache (does NOT reduce gut motility or cause rebound constipation/ileus!)
- Toxic megacolon and paralytic ileus (if Loperamide is used in invasive bacterial/amoebic dysentery or young children); supratherapeutic Loperamide abuse causes fatal QTc prolongation
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- P-gp inhibitors (Quinidine, Ritonavir, Itraconazole, Verapamil) allow Loperamide to cross the blood–brain barrier causing central opioid respiratory depression
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: ORS is the primary life-saving treatment for diarrhoea; NEVER give Loperamide (Imodium/Eldoper) to young children or anyone with bloody stools or high fever (Racecadotril sachets + ORS + Zinc 20 mg OD are used in children)
- Meal & Clock Timing Instruction: Always administer alongside oral rehydration solution (WHO Low-Osmolarity ORS)! (Loperamide: After each loose stool. Racecadotril: Three times daily before main meals)
- Missed Dose Protocol: Stop once formed stools return
- Geriatric Dispensing Pearl: Avoid high doses of Loperamide in older adults due to faecal impaction and paralytic ileus risk
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Loperamide Tablets/Capsules: 2 mg. Racecadotril: 100 mg Capsules (Adults); 10 mg & 30 mg Paediatric Granules/Sachets
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 05 [5.18] (p. 68)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [5.22] Mesalazine (5-Aminosalicylic Acid — 5-ASA) & Sulfasalazine — Colonic Topical Anti-Inflammatory Salicylate & Disease-Modifying
- [5.8]-CMP21 Betahistine Dihydrochloride, Cinnarizine & Flunarizine — Synthetic Non-Absorbable Disaccharide (Galactose-Fructose); Osmot
- [5.12]-C22 Magnesium Hydroxide — Local Gastric Acid Neutralisers (Non-Systemic Antacids) with Anti
- [5.12]-C23 Simethicone / Magaldrate / Oxetacaine — Local Gastric Acid Neutralisers (Non-Systemic Antacids) with Anti
